Renhe Pharmacy Co (SZSE:000650) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Other Net Income (Loss)?

Renhe Pharmacy Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Renhe Pharmacy Co's quarterly Other Net Income (Loss) increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥0 Mil) and increased from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥0 Mil).

Renhe Pharmacy Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥-0 Mil) but then increased from Dec. 2022 (¥-0 Mil) to Dec. 2023 (¥-0 Mil).

Renhe Pharmacy Co Other Net Income (Loss) Historical Data

The historical data trend for Renhe Pharmacy Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Other Net Income (Loss) Chart

Renhe Pharmacy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Renhe Pharmacy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Renhe Pharmacy Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Renhe Pharmacy Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Renhe Pharmacy Co (SZSE:000650) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038

Website

http://www.renheyaoye.com

Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.

Renhe Pharmacy Co (SZSE:000650) Headlines

No Headlines